FDA Inspection
Guangxi Yulin Pharmaceutical Group Co. Ltd.FDA Inspection 1268116 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - March 21, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Guangxi Yulin Pharmaceutical Group Co. Ltd., with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 21, 2025
- Product Type
- Human Drugs
Open in Dashboard
ID · 82a89afe-506e-4e84-9dd2-02a225853a04